Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
11/10/2005 | US20050250949 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same |
11/10/2005 | US20050250834 11-(Aminoalkyl)isoindolo[2,1-a]indol-6-ones: 11-(2-Dimethylaminoethyl)-2-fluoroisoindolo[2,1-a]indol-6-one; psychological disorders, drug abuse, sleep disorders, Alzheimer's, Parkinson's and Huntington's disease, Irritable bowel syndrome, chemotherapy induced emesis, spinal trauma and/or head injury |
11/10/2005 | US20050250819 Inhibitors of bacterial type III protein secretion systems |
11/10/2005 | US20050250814 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
11/10/2005 | US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus |
11/10/2005 | US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof |
11/10/2005 | US20050250771 Substituted indoles and their use as integrin antagonists |
11/10/2005 | US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
11/10/2005 | US20050250762 Crystalline polymorph of bazedoxifene acetate |
11/10/2005 | US20050250760 1-[(Indol-3-yl)carbonyl]piperazine derivatives |
11/10/2005 | US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof |
11/10/2005 | US20050250741 non-steroidal agonists and antagonists; 2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-1H-indole-5--carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
11/10/2005 | US20050250740 Novel indole derivatives as selective androgen receptor modulator (SARMS) |
11/10/2005 | US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
11/10/2005 | US20050250706 Processes for the preparation of alpha polymorph of perindopril erbumine |
11/10/2005 | CA2565018A1 Fused quinoline derivative and use thereof |
11/10/2005 | CA2564613A1 Pseudopeptides growth hormone secretagogues |
11/10/2005 | CA2564258A1 Histamine-3 receptor antagonists |
11/10/2005 | CA2563903A1 Process for preparing dipeptidyl iv inhibitors and intermediates therefor |
11/10/2005 | CA2563063A1 Purification of progesterone receptor modulators |
11/10/2005 | CA2562627A1 Preparation of tegaserod and tegaserod maleate |
11/09/2005 | EP1592772A2 5ht7 antagonists and inverse agonists |
11/09/2005 | EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors |
11/09/2005 | EP1511726B1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol |
11/09/2005 | EP1252166B1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them |
11/09/2005 | EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
11/09/2005 | EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
11/09/2005 | EP0929521B1 Nmda (n-methyl-d-aspartate) antagonists |
11/09/2005 | CN1694873A Vanilloid receptor ligands and their use in treatments |
11/09/2005 | CN1694869A Substituted spirocyclic ketoenols |
11/09/2005 | CN1694868A Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation |
11/09/2005 | CN1694867A Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
11/09/2005 | CN1694866A 4-piperazinylindole derivatives with 5-HT6 receptor affinity |
11/09/2005 | CN1694703A Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis |
11/09/2005 | CN1693998A Hydrazone-based charge transport materials |
11/09/2005 | CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide |
11/09/2005 | CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same |
11/08/2005 | US6962995 Phenanthroline derivatives |
11/08/2005 | US6962940 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders |
11/08/2005 | US6962939 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
11/08/2005 | US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors |
11/08/2005 | CA2157288C Methods and compositions for inhibition of angiogenesis |
11/03/2005 | WO2005102998A1 Novel androgens |
11/03/2005 | WO2005102321A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
11/03/2005 | WO2005102320A1 Medicinal agent for treating viral infections |
11/03/2005 | WO2005069930A3 Asymmetric hydrogenation of alpha-amino carbonyl compounds |
11/03/2005 | WO2002004440A9 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
11/03/2005 | US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue |
11/03/2005 | US20050245741 Novel tricyclic spiropiperidines or spiropyrrolidines |
11/03/2005 | US20050245595 Positive modulators of nicotinic receptor agonists |
11/03/2005 | US20050245593 4-Aminomethyl-1-aryl-cyclohexylamine compounds |
11/03/2005 | US20050245592 2-Iminopyrrolidine derivatives |
11/03/2005 | US20050245590 Crystalline forms of imidoalkanpercarboxylic acids |
11/03/2005 | US20050245573 N-substituted benzene sulfonamides |
11/03/2005 | US20050245565 Diamine derivatives |
11/03/2005 | US20050245543 Histamine-3 receptor antagonists |
11/03/2005 | US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
11/03/2005 | US20050245515 Indolyl derivatives as liver-X-receptor (LXR) modulators |
11/03/2005 | US20050245511 Novel compounds that inhibit tryptase activity |
11/03/2005 | US20050245507 7-Phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
11/03/2005 | US20050245500 Beta-ketoamide compounds with MCH antagonistic activity |
11/03/2005 | US20050244733 Hydrazone-based charge transport materials |
11/03/2005 | CA2562571A1 Novel androgens |
11/02/2005 | EP1591836A1 Hydrazone-based charge transport materials |
11/02/2005 | EP1591832A2 Photosensitive composition, compound used in the same, and patterning method using the same |
11/02/2005 | EP1591510A2 Organic electroluminescence device |
11/02/2005 | EP1591441A1 Carboxylic acid compounds |
11/02/2005 | EP1590338A2 Modulators of melanocortin receptor |
11/02/2005 | EP1590325A1 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
11/02/2005 | EP1590324A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb |
11/02/2005 | EP1590322A1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof |
11/02/2005 | EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
11/02/2005 | EP1590314A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
11/02/2005 | EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors |
11/02/2005 | EP1083905B1 Medical use of a selective estrogen receptor modulator in combination with a sex steroide precursor |
11/02/2005 | EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases) |
11/02/2005 | EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors |
11/02/2005 | EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
11/02/2005 | CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
11/02/2005 | CN1692099A Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2, 4-dione derivatives serving as pesticides |
11/02/2005 | CN1225462C New piperazine and piperidine compounds |
11/01/2005 | US6960666 administering an azabicyclo or azatricyclo compound to treat inflammatory diseases such as asthma |
11/01/2005 | US6960665 Process for arylating or vinylating or alkynating a nucleophilic compound |
11/01/2005 | US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
11/01/2005 | US6960611 Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof |
11/01/2005 | US6960608 Fused indazoles and indoles and their use for the treatment of glaucoma |
11/01/2005 | US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
11/01/2005 | US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes |
11/01/2005 | US6960579 administering a compound containing a biheterocylic ring with sulfonamide group: sleeping disorder, depression, anxiety, circadian rhythm disorders |
11/01/2005 | US6960572 Indolinones and uses thereof |
11/01/2005 | US6960355 Modified amino acid compounds useful in delivery of active agents |
10/27/2005 | WO2005100505A1 New organic luminescent element |
10/27/2005 | WO2005100351A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR |
10/27/2005 | WO2005100345A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
10/27/2005 | WO2005100334A1 Dipeptidyl peptidase-iv inhibitors |
10/27/2005 | WO2005100323A1 Process for preparing pyridazinone compounds |
10/27/2005 | WO2005100318A1 Alkanoic acids and their esters as antidiabetic agents |
10/27/2005 | WO2005100317A1 Process for the preparation of perindopril |
10/27/2005 | WO2005100316A1 Crystalline polymorph of a bazedoxifene acetate |
10/27/2005 | WO2005100315A1 Bazedoxifene ascorbate as selective estrogen receptor modulator |